Psoriatic Arthritis Treatment in Mumbai

Psoriatic arthritis (PsA) is inflammatory arthritis that affects people with psoriasis, a skin condition that causes a red, scaly rash. Psoriatic arthritis usually affects the skin and joints, causing them to swell, stiffen, and hurt. If left untreated, inflammation can cause damage to joints and tissues over time.

Psoriatic Arthritis Early Signs: 11 Signs and Symptoms to Watch For

 

Psoriatic arthritis has no known cure. Controlling inflammation in your affected joints to prevent joint pain and disability, as well as controlling skin involvement, are the main goals of treatment. Prescription pharmaceuticals known as disease-modifying antirheumatic drugs are one of the most prevalent therapies (DMARDs).

Frequently Asked Questions

Anti-inflammatory drugs such as nonsteroidal anti-inflammatory drugs (NSAIDs) and, at times, low-dose prednisone given orally or by intra-articular glucocorticoid injections are used as first-line therapy in PsA, always taking into account existing comorbidities, particularly premature cardiovascular disease.

Anti-inflammatory drugs such as nonsteroidal anti-inflammatory drugs (NSAIDs) and, at times, low-dose prednisone given orally or by intra-articular glucocorticoid injections are used as first-line therapy in PsA, always taking into account existing comorbidities, particularly premature cardiovascular disease.

Psoriasis and psoriatic arthritis are treated with biologics such as Enbrel, Cosentyx, and Humira. Because these drugs are so specific, they may have fewer adverse effects than conventional therapy alternatives. These medications impair immunological function by inhibiting a protein that is crucial to the immune system.

A rheumatologist is a clinician who specializes in the diagnosis and treatment of arthritis and associated joint, muscle, and bone illnesses. Psoriatic arthritis is most commonly diagnosed and treated by rheumatologists and dermatologists.

In 2020, the FDA will approve the use of guselkumab (Tremfya), a novel interleukin blocker, to treat PsA. It's the first PSA medication to directly target interleukin-23 (IL-23), a cytokine linked to inflammation in the disease.

Book an Appointment

Enter details,our team would approach to help you as soon as possible.

Phone icon